Comparison Between Natural Sleep Endoscopy and Drug-induced Sleep Endoscopy in Patients With Obstructive Sleep Apnea
1 other identifier
interventional
40
1 country
1
Brief Summary
Drug-induced sleep endoscopy (DISE) is the most used technique for identifying the obstruction site associated with obstructive sleep apnea (OSA). This is due to the fact that it allows many patients to be examined in a daytime setting. This procedure uses sedative drugs to mimic natural sleep. However, associations with the site of upper airway (UA) collapse during natural sleep remain unclear. The aim of this explorative study is to identify UA collapse in patients with OSA using endoscopic techniques as well as flow shape characteristics and sound analyses during natural and drug-induced sleep. Furthermore, we want to optimize the measurement set-up of natural sleep endoscopy (NSE).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 26, 2021
CompletedFirst Posted
Study publicly available on registry
January 28, 2021
CompletedStudy Start
First participant enrolled
March 30, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedJuly 26, 2021
July 1, 2021
1.4 years
January 26, 2021
July 19, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Endoscopic Classification System
Comparison of the frequencies of the site, gradation and pattern of upper airway collapse between natural and drug-induced sleep endoscopy.
Immediately, during the procedure
Secondary Outcomes (2)
Flow shape analysis
Immediately, during the procedure
Acoustic analysis
Immediately, during the procedure
Other Outcomes (9)
Apnea-hypopnea index (AHI)
Immediately, during polysomnography
Oxygen desaturation index (ODI)
Immediately, during polysomnography
Oxygen saturation (SaO2)
Immediately, during polysomnography
- +6 more other outcomes
Study Arms (2)
Natural sleep
OTHERNatural sleep endoscopy (NSE) OSA patients will be endoscopically evaluated during natural sleep. During NSE additional physiological measurements (flow shape analysis, acoustic analysis of snoring sounds and esophageal pressure measurements) will be carried out.
Drug-induced sleep
OTHERDrug-induced sleep endoscopy (DISE) OSA patients will be endoscopically evaluated during drug-induced sleep. During DISE additional physiological measurements (flow shape analysis, acoustic analysis of snoring sounds and esophageal pressure measurements) will be carried out.
Interventions
An intravenous bolus injection of midazolam 1.5 mg will be used to induce sleep. Maintenance of sedated sleep will be obtained by a target-controlled infusion of propofol (2.0-3.0 µg/mL).
Eligibility Criteria
You may qualify if:
- Diagnosis of OSA with a baseline AHI ≥ 15 per hour based on full polysomnography
- Body mass index (BMI) ≤ 35 kg/m²
- Capability of giving informed consent and willingness to undergo NSE
You may not qualify if:
- Central sleep apnea (defined as CAHI ≥ 30% of total AHI)
- Inability to sleep in a supine position due to a medical condition
- Inability of the patient to understand and/or comply to the study procedures
- Neuromuscular disorders or craniofacial anomalies affecting the UA
- Sedative medication use (opioids and muscle relaxants)
- Active psychiatric disorders (psychotic illness, major depression, anxiety attacks, excessive alcohol or drug use)
- Severe or decompensated cardiac or respiratory diseases
- Medical history of known causes of tiredness by day or severe sleep disruption (insomnia, PLMS, narcolepsy)
- Contra-indications for DISE: i.e. fitness for general anesthesia (ASA\>3), allergy to sedative agent(s) and an expected extremely difficult airway
- Pregnancy or willing to become pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Antwerp University Hospital
Edegem, Antwerp, 2650, Belgium
Related Publications (1)
Van den Bossche K, Van de Perck E, Wellman A, Kazemeini E, Willemen M, Verbraecken J, Vanderveken OM, Vena D, Op de Beeck S. Comparison of Drug-Induced Sleep Endoscopy and Natural Sleep Endoscopy in the Assessment of Upper Airway Pathophysiology During Sleep: Protocol and Study Design. Front Neurol. 2021 Dec 7;12:768973. doi: 10.3389/fneur.2021.768973. eCollection 2021.
PMID: 34950101DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Olivier Vanderveken, MD, PhD
University Hospital, Antwerp
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- NSE and DISE will be performed by two separate researchers, blinding the ENT surgeon who performs the NSE or DISE for the outcome of the other procedure. This is a blinded study and the researchers will have no knowledge of the patient's characteristics / demographic variables and their history.
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Olivier Vanderveken, Professor and Chair Otorhinolaryngology
Study Record Dates
First Submitted
January 26, 2021
First Posted
January 28, 2021
Study Start
March 30, 2021
Primary Completion
August 31, 2022
Study Completion
December 31, 2022
Last Updated
July 26, 2021
Record last verified: 2021-07